Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors.

A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle ...

Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

There are a few unusual things about the infant botulism outbreak that prompted formula maker ByHeart to recall all of its ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

The deals keeps coming. Merck this morning said it will acquire Cidara Therapeutics, the maker of an experimental flu therapy ...

Merck agreed to buy Cidara Therapeutics, the maker of an experimental flu therapy, in a $9.2 billion deal, as the ...

Restrictions on gender-affirming care for minors consistently allow exceptions for minors with intersex traits, a new study ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

Jenna Norton, a vocal critic of Trump administration actions at the NIH, was abruptly placed on administrative leave this ...

Weight loss drugs have skyrocketed in prevalence in recent years, according to a new KFF poll on GLP-1 drugs and drug prices.

There are many reasons why a 79-year-old man might need to get an MRI scan of his brain, some benign, some more concerning.